Explore how Bayesian statistical methods are reshaping clinical trial design. Learn how FDA support, adaptive decision-making, and external data use are driving innovation and…
Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical studies, predict DDIs, and support asciminib’s approval.
